Literature DB >> 3572937

Toxicity of methotrexate in rheumatoid arthritis.

J G Gispen, G S Alarcón, J J Johnson, R T Acton, B O Barger, W J Koopman.   

Abstract

Seventy-two patients with rheumatoid arthritis had been treated with pulse weekly oral methotrexate with a mean followup of one year. Minor side effects (oral ulcers, transient elevation of liver enzymes, nausea, vomiting) were present in 46 patients (63.8%), whereas major side effects (severe infection, cytopenia, respiratory failure, seizures, gastrointestinal bleeding) were present in 7 (9.7%), 2 of whom died. Patients with major side effects had shorter disease duration and increased frequency of extraarticular manifestations as compared to those with no side effects. No association between a particular clinical or genetic variable and occurrence of side effects to methotrexate was found.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572937

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  20 in total

Review 1.  Lung disease in rheumatoid arthritis.

Authors:  Zulma X Yunt; Joshua J Solomon
Journal:  Rheum Dis Clin North Am       Date:  2015-02-03       Impact factor: 2.670

2.  Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up.

Authors:  A A Drosos; D Psychos; A P Andonopoulos; S Stefanaki-Nikou; E B Tsianos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

3.  Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis.

Authors:  N J Cook; G J Carroll
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

4.  Variability of oral bioavailability for low dose methotrexate in rats.

Authors:  T Kuroda; K Namba; T Torimaru; S Yamamoto; M Akahori
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

5.  A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy.

Authors:  M Tishler; D Caspi; Z Halperin; M Baratz; M Moshkowitz; M Yaron
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 6.  Drug toxicity.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 7.  Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.

Authors:  F Salaffi; P Manganelli; M Carotti; S Subiaco; G Lamanna; C Cervini
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

8.  Rheumatoid arthritis - an update for general dental practitioners.

Authors:  S de Souza; R K Bansal; J Galloway
Journal:  Br Dent J       Date:  2016-11-18       Impact factor: 1.626

Review 9.  Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells.

Authors:  Pan Zheng; Xing Chang; Qianjin Lu; Yang Liu
Journal:  J Autoimmun       Date:  2013-02-01       Impact factor: 7.094

10.  Methotrexate in refractory rheumatoid arthritis.

Authors:  A M Boerbooms; M E Jeurissen; A A Westgeest; H Theunisse; L B Van de Putte
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.